NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is 67076P102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $3,000 | +200.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2015 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2015 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2014 | $1,000 | -75.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2014 | $4,000 | -20.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2014 | $5,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2014 | $5,000 | -16.7% | 1,000 | 0.0% | 0.00% | – |
| Q4 2013 | $6,000 | -14.3% | 1,000 | 0.0% | 0.00% | – |
| Q3 2013 | $7,000 | +16.7% | 1,000 | 0.0% | 0.00% | – |
| Q2 2013 | $6,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 200,190 | $657,000 | 0.03% |
| WMS Partners, LLC | 65,555 | $215,000 | 0.03% |